The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,405.00
Bid: 2,400.00
Ask: 2,410.00
Change: -20.00 (-0.82%)
Spread: 10.00 (0.417%)
Open: 2,435.00
High: 2,435.00
Low: 2,405.00
Prev. Close: 2,425.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Voting Update

4 Sep 2023 12:51

RNS Number : 3096L
Morgan Sindall Group PLC
04 September 2023
 

Morgan Sindall Group plc

Legal Entity Identifier (LEI) number: 2138008339ULDGZRB345

 

4 September 2023

Morgan Sindall Group plc ("the Company")

 

Update on response to 2023 AGM voting outcome

 

At our Annual General Meeting ('AGM') held on 4 May 2023, resolution 3 (Approval of the Directors' Remuneration Policy) was supported by a large majority of shareholders but received less than 80% support overall.

 

In advance of the 2023 AGM, the Remuneration Committee (the 'Committee') undertook a detailed engagement with the Company's largest shareholders in relation to the remuneration proposals, and had amended the final Remuneration Policy design in response to feedback received. Following the 2023 AGM, the Committee reached out to the Company's largest shareholders to continue the dialogue and listen to their views - and in particular to understand why those who either abstained or voted against the Directors' Remuneration Policy ('the 'Policy') had done so.

 

The Committee received responses from eight investors, the majority of whom reconfirmed support for the Policy and the management team. 

 

One shareholder raised the annual bonus deferral requirement and 2nd-year phasing down of the post-employment shareholding requirement as their reason for not supporting the resolution. In both cases the Committee is comfortable that its current approach supports appropriate alignment of executive and shareholder interests. In respect of the annual bonus deferral requirement, the Committee also considers this requirement appropriate given the current shareholdings of incumbent Executive Directors. However, the Committee will reconsider both of these Policy design features as part of the next Policy review.

 

The Committee also received feedback from two shareholders that their voting had reflected the 'against' recommendation from one of the major proxy voting agencies, which itself was primarily a result of the simultaneous increases to the Policy headroom available under the annual bonus and LTIP schemes. On this matter, the Committee maintains its view that the Policy should be sufficiently flexible to last for a full triennial review period rather than needing to revert to shareholders to seek incremental changes, and reiterates its commitment to write out to major shareholders in advance of using the increased maximum opportunities under either of the variable incentives.

 

Another shareholder requested that the Committee provide a full explanation in its Remuneration Report of the rationale for the adoption of any increase to the executive directors' incentive opportunities in future years, particularly in relation to the achievement of key strategic objectives, and this feedback is consistent with the current thinking of the Committee.

 

The Committee continues to be grateful for the feedback received and the two-way engagement with major shareholders. Given overall majority support was obtained for the Policy resolution, it is not proposed to make any further changes to the approach to remuneration that was set out in the 2022 Annual Report. The Company will, however, continue to keep the Policy under review over the coming years and welcomes ongoing dialogue with shareholders and proxy advisers.

 

 

Enquiries:

Clare Sheridan, Company Secretary +44 (0) 20 7307 9200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZLFBXKLEBBF
Date   Source Headline
8th Apr 20218:00 amRNSDirectorate Change
1st Apr 202111:59 amRNSTotal Voting Rights
25th Mar 202112:51 pmRNSAnnual Financial Report
12th Mar 20214:37 pmRNSHolding(s) in Company
11th Mar 20214:55 pmRNSDirector/PDMR Shareholding
10th Mar 20213:01 pmRNSDirector/PDMR Shareholding
8th Mar 20214:54 pmRNSDirector/PDMR Shareholding
8th Mar 20214:28 pmRNSDirector/PDMR Shareholding
5th Mar 20213:06 pmRNSDirector/PDMR Shareholding
1st Mar 202111:25 amRNSTotal Voting Rights
25th Feb 20217:00 amRNSFinal Results
17th Feb 20219:06 amRNSHolding(s) in Company
8th Feb 20217:00 amRNSNotice of Results
3rd Feb 20213:42 pmRNSHolding(s) in Company
1st Feb 202110:40 amRNSTotal Voting Rights
22nd Jan 20214:58 pmRNSHolding(s) in Company
4th Jan 202110:56 amRNSTotal Voting Rights
8th Dec 20202:00 pmRNSAdditional Listing
7th Dec 20209:23 amRNSDirector Declaration
3rd Dec 20203:20 pmRNSDirector/PDMR Shareholding
1st Dec 202012:55 pmRNSTotal Voting Rights
4th Nov 20203:00 pmRNSDividend Declaration
4th Nov 20207:00 amRNSTrading Update
2nd Nov 202012:24 pmRNSTotal Voting Rights
20th Oct 20209:57 amRNSBlock listing Interim Review
1st Oct 20201:28 pmRNSTotal Voting Rights
23rd Sep 20205:00 pmRNSHolding(s) in Company
18th Sep 202012:02 pmRNSPrice Monitoring Extension
15th Sep 202010:00 amRNSAdditional Listing
9th Sep 20202:49 pmRNSHolding(s) in Company
2nd Sep 202012:07 pmRNSSecond Price Monitoring Extn
2nd Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20209:11 amRNSTotal Voting Rights
25th Aug 20204:06 pmRNSHolding(s) in Company
21st Aug 20204:15 pmRNSHolding(s) in Company
6th Aug 202012:25 pmRNSHolding(s) in Company
5th Aug 20207:00 amRNSHalf-year Report
3rd Aug 20209:54 amRNSTotal Voting Rights
27th Jul 20207:00 amRNSForward funding secured for £185m New Victoria
14th Jul 20208:30 amRNS£252m forward funding deal of Lewisham Gateway
7th Jul 20203:21 pmRNSHolding(s) in Company
6th Jul 20207:00 amRNSNotice of Results
1st Jul 20202:49 pmRNSHolding(s) in Company
1st Jul 20208:50 amRNSTotal Voting Rights
25th Jun 20203:29 pmRNSHolding(s) in Company
22nd Jun 202011:27 amRNSDirector Declaration
18th Jun 20202:02 pmRNSHolding(s) in Company
10th Jun 202012:02 pmRNSPrice Monitoring Extension
1st Jun 202011:48 amRNSTotal Voting Rights
28th May 20202:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.